Although research linking ANG to ALS has been reported since 2006, the unclear pathogenic mechanism has prevented the development of gene therapy targeting ANG mutations, and clinical trials or animal experiments involving targeted drugs are needed. This evidence concerns the gene ANG and amyotrophic lateral sclerosis.